Evidence map›Paper›PMID 34444516›Full record

ReviewInternational journal of environmental research and public health2021

Autosomal Dominant Hypophosphatemic Rickets: A Case Report and Review of the Literature.

Chiara Mameli, Arianna Sangiorgio, Valeria Colombo, Mirko Gambino, Luigina Spaccini, Elisa Cattaneo, Gian Vincenzo Zuccotti

Abstract readCase ReportsReview
In one paragraph

Review in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Autosomal dominant hypophosphatemic rickets: a case report of two sisters with a novel FGF-23 mutation.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chiara MameliDepartment of Pediatrics, V. Buzzi Children's Hospital, Università di Milano, Via Lodovico Castelvetro, 32, 20154 Milan, Italy.ORCID 0000-0002-6768-3411
Arianna SangiorgioDepartment of Pediatrics, V. Buzzi Children's Hospital, Università di Milano, Via Lodovico Castelvetro, 32, 20154 Milan, Italy.
Valeria ColomboDepartment of Pediatrics, V. Buzzi Children's Hospital, Università di Milano, Via Lodovico Castelvetro, 32, 20154 Milan, Italy.
Mirko GambinoDepartment of Pediatrics, V. Buzzi Children's Hospital, Università di Milano, Via Lodovico Castelvetro, 32, 20154 Milan, Italy.
Luigina SpacciniClinical Genetics Service, V. Buzzi Children's Hospital, Università di Milano, Via Lodovico Castelvetro, 32, 20154 Milan, Italy.
Elisa CattaneoClinical Genetics Service, V. Buzzi Children's Hospital, Università di Milano, Via Lodovico Castelvetro, 32, 20154 Milan, Italy.
Gian Vincenzo ZuccottiDepartment of Pediatrics, V. Buzzi Children's Hospital, Università di Milano, Via Lodovico Castelvetro, 32, 20154 Milan, Italy.ORCID 0000-0002-2795-9874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal dominant hypophosphatemic rickets (ADHR) is an extremely rare form of genetic rickets caused by mutations in the fibroblast growth factor 23 gene. ADHR is characterized by hypophosphatemia secondary to isolated renal phosphate wasting. Only a few cases of ADHR have been reported in the literature to date. We describe the case of a 17-month-old girl who presented with severe failure to thrive (length: -4.08 standard deviation (SD), weight: -2.2 SD) and hypotonia. Hypophosphatemia, decreased tubular phosphate reabsorption (69%), and rachitic lesions were found. Genetic analysis showed the heterozygous variant c.536G>A (NM_020638.3:c.536G>A) in exon 3 of the FGF23 gene, leading to the diagnosis of ADHR. She was treated with phosphate salts and oral alfacalcidol. After 4 years of treatment, at 5 years of age, the patient's ADHR resolved spontaneously. Considering the lack of knowledge regarding ADHR, we reviewed the literature to describe the features of this rare and poorly understood disease. Eleven ADHR pediatric cases have been described thus far, with cases tending to be more common in females than males. Similar to the general population, two groups of patients with ADHR can be described depending on the mutations present: patients with an R179 and R176 mutation have early-onset of disease and higher frequency of rickets, and a milder and late-onset of disease, respectively. Symptoms and disease severity may fluctuate. Spontaneous remission may occur during the pediatric age.

Indexed as

Familial Hypophosphatemic RicketsFibroblast Growth FactorsChildFemaleFibroblast Growth Factor-23HumansInfantIronMaleMutationPhosphatesFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsIronPhosphateschildrenfibroblast growth factor 23 genehypophosphatemiarickets

Identifiers

PMID34444516
PMCPMC8392413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.